Comparison of side effects of bromocriptine and cabergoline: Which is more significant?

Bromocriptine and cabergoline are two medications commonly used to treat different conditions, but both may cause some side effects.

Bromocriptine is mainly used to treat prolactinoma and inhibit physiological lactation. Common side effects include headache, nausea, vomiting, orthostatic hypotension, fatigue and dizziness. When taking large doses, symptoms such as dry mouth, hallucinations, and movement disorders may also occur. In addition, bromocriptine may also cause metabolic changes, such as weight gain, abnormal increases in blood lipids and blood glucose levels, and increase the patient's risk of diabetes and cardiovascular disease.

Cabergoline is mainly used to treat Parkinson's disease, hyperprolactinism and other diseases. The main side effects include nausea, vomiting, drowsiness, constipation, etc. In addition, cabergoline may also cause head discomfort reactions, such as dizziness, headache, and nervous system discomfort reactions, such as nasal congestion. It should be noted that although cabergoline has high specificity for D2 receptors, it may also aggravate symptoms such as arrhythmia and angina pectoris.

According to publicly released information, cabergoline has relatively minor side effects, but the probability of occurrence is relatively high; while bromocriptine has more significant side effects, but the probability of occurrence is relatively low. The side effects of bromocriptine involve multiple systems, including the digestive system, nervous system, metabolic system, etc.; while cabergoline mainly focuses on discomfort reactions in the digestive system, head and nervous system.

When considering long-term use, special attention needs to be paid to the possible metabolic changes and cardiovascular risks of bromocriptine. Although the side effects of cabergoline are relatively minor, attention should still be paid to the possible cardiac arrhythmia and other problems it may cause.